Chapter 153 Tan Ting’s Second Report

After returning to school, Lu Liang once again dug out his experimental plan, and he slightly modified the plan.

Replace some key drug sample information with letters such as A and B.

In addition, Lu Liang also left a separate batch of experiments. The purpose of this batch of experiments was mainly to practice Wang Wentao's skills.

After confirming that there were no problems with the plan, Lu Liang sent the plan to Manager Nie.

Soon, Lu Liang received a reply from Manager Nie, who said that he was already arranging trials.

However, the number of two thousand mice is a bit too much, and it may take some time to prepare.

After reaching an agreement with Manager Nie, Lu Liang no longer had to worry about the experiment.

Manpower and space, these two problems will be solved by the biological company.

After arranging all the things, Lu Liang stretched hard and climbed into bed to get ready for sleep.

Yu Qing returned to his rental house after get off work late at night. As a social worker in his thirties, he was overwhelmed by the pressure of 996 hours of work every day.

But Yu Qing did not dare to complain at all and could only silently endure the company's oppression.

After taking off his coat, Yu Qing lay on the bed and turned on his mobile phone. After he opened the chat history, he found that his mother had sent him several voice messages.

Yu Qing clicked on voice and heard his mother's voice coming from the phone.

"Son, don't worry. Your dad went for a review today. The doctor said that your dad's condition is still stable."

After hearing his mother's words, Yu Qing seemed to be relieved.

Then he transferred a sum of money to his mother from his newly paid salary, which was used for his father's medical expenses.

After completing the transfer, Yu Qing took a look at the balance in his bank card and couldn't help but sigh.

Just last year, his elderly father was unfortunately diagnosed with lung cancer and required chemotherapy, hospitalization, and medication.

Especially his father’s subsequent treatment will require more than 10,000 bottles of sugalimab.

The heavy medical expenses wiped out Yu Qing's few savings. He had to spend all the money he had saved for getting married and buying a house.

This made Yu Qing feel overwhelmed all of a sudden.

He originally planned to change jobs, but with the emergence of this situation, Yu Qing immediately gave up his idea of ​​​​changing jobs.

Fortunately, things took a turn for the better not long ago.

He saw a piece of news in the patient group. It was said that a man named Lu Liang was leading a team to develop anti-lung cancer drugs.

After the drug is released, their lung cancer will be cured.

Although Yu Qing is not sure who this Lu Liang is, from listening to the chats of the patients, Yu Qing can vaguely feel that this Lu Liang seems to be very powerful. He has developed many drugs before, and the price of each drug is very high. All very cheap.

Otherwise, he would not be so highly regarded by his fellow patients.

This made Yu Qing suddenly see hope again.

After Yu Qing explained his mother, he opened a group of patients as usual.

Because of this incident these days, the patients in the patient group have been very lively.

But unexpectedly, when Yu Qing opened the patient group today, he immediately noticed that the patient group seemed to be particularly quiet today.

The atmosphere in the group was heavy and depressing.

This made Yu Qing frown. What happened today?

Yu Qing quickly scrolled through the previous chat history in the group.

Soon, he found the source of the matter, which all originated from a report forwarded by a patient in the group.

Yu Qing quickly opened the report. However, when he saw the title of the report, Yu Qing was slightly stunned.

The title of the report is: "Sugemalimab, the best lung cancer treatment drug after ten years of hard research and development." 》

Yu Qing is very familiar with the reporter who wrote the report. Isn't this the same reporter who wrote the previous report on conscience medicine?

Yu Qing then read on. At the beginning of the report, he first introduced the developer of sugalimab, a female doctor named Zheng Yi.

Immediately afterwards, the report described at length the amazing achievements of this female doctor in the past, including that she graduated from Johns Hopkins University and how many high-impact papers she published during her doctorate.

One of the papers was published in the official issue of Cell.

Although Yu Qing didn't understand these things, even if he couldn't understand them, he could still feel that this female doctor was very powerful.

Immediately afterwards, this report introduced how this female doctor developed the drug sugalimab for almost decades.

How much money was spent on the research and development process, how many technical personnel were involved, and finally the drug sugalimab was successfully developed.

At the end of the article, the female doctor made a clear and confident statement in the interview.

She knew that Lu Liang was very talented in drug research, and she also believed that it was only a matter of time before Lu Liang made anti-lung cancer drugs.

But she was very confident that even if Lu Liang made an anti-lung cancer drug, the efficacy of the drug would definitely not be as good as sugalimab.

Later, the female doctor said that Moco will put the clinical trial data of sugalimab on its official website. If you don't believe it, you can make a comparison at that time.

After reading the report, Yu Qing's heart suddenly sank, and he felt a little out of breath.

It was as if the little hope that had just been ignited was extinguished by an invisible hand.

The comment area below this report is already abuzz, with netizens from all walks of life expressing their views and opinions.

"Have you seen it? There is a reason why it is expensive. For a drug that took ten years to be developed, the price of more than 10,000 yuan is already considered reasonable."

"I don't think so. Why is that female doctor so sure that sugalimab is the best drug?"

"Forget it about the person upstairs. You don't even look at what academic qualifications he has. He graduated from Johns Hopkins University with a Ph.D., what kind of concept? No matter how powerful Lu Liang is, he is just an undergraduate. There is no big difference between the two. The two of them have studied it. Can the medicines be the same?"

"Why are there still people talking about academic qualifications? Some people really think that Lu Shen's level is just an undergraduate, right?"

"Why are you making excuses? Dr. Zheng Yi graduated from a well-known medical school abroad. His level is lower than Lu Liang's. Don't be ridiculous."

Now there was a complete quarrel in the comment area, and all parties had their own reasons. This made Yu Qing not know who was right for a while.

After a moment of silence, Yu Qing silently turned off his phone.

But an idea that had never occurred to him before suddenly appeared in Yu Qing's mind at this moment.

What if the drug developed by Lu Liang is indeed not as effective as sugalimab.

You know, his father has not yet been treated with sugalimab, but is only being maintained with other cheaper drugs.

The purpose is to wait until the day Lu Liang's drug is launched.

But if Lu Liang's drug treatment is not as effective as sugalimab, then so many days of waiting will be in vain. During this period, his father's illness has been getting worse.

Fear, hesitation, uneasiness and other emotions surged into Yu Qing's heart.